Institut Curie

This study tested a new drug called PLX038 in 14 people with advanced triple-negative breast cancer that had already been treated. The goal was to see if the drug could shrink tumors. The trial was terminated early, so results are limited.

This early-phase study tested a combination of two experimental drugs (tuvusertib and PLX038) in people with advanced solid tumors that could not be cured. The goal was to find a safe dose and see if the drugs could shrink tumors. Only 10 people were enrolled before the study was…

This study tested a drug called PF-05212384 in people with certain aggressive blood cancers (leukemia or related conditions) that came back or didn't respond to treatment. The goal was to see if the drug could shrink or control the cancer. Only 10 people took part before the stud…

This study looked at whether a special hemostatic dressing can reduce bleeding when changing bandages on bleeding cancer wounds. Four adults with malignant wounds took part. The goal was to find a way to stop bleeding and prevent it from coming back, while also checking pain and …

This study aimed to see if DNA from cervical cancer tumors can be found in the blood of patients. Researchers wanted to know if this could help detect early signs of cancer spread. The study included 26 patients with cervical cancer and used blood samples to look for tumor DNA.